Endocrine, metabolic & immune disorders drug targets · 2026
A Comparison between LTT and CFSE Proliferation Tests in Patients with Inborn Errors of Adaptive Immunity.
СтатьяСравнительное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Shad Tannaz Moeini, Taghizadeh Nima, Delavari Samaneh, Aghamohamadi Nazanin, Mehrabadi Ali Zarezadeh, Salami Fereshte, Mohammadi Soha, Salehi Helia, Fekrvand Saba, Tavakol Marzieh, Fathi Nazanin, Chavoshzadeh Zahra, Mesdaghi Mehrnaz, Ghadrdan Mahsa, Shafiei Alireza, Rezaei Nima, Yazdani Reza, Abolhassani Hassan
Аннотация
BACKGROUND: Inborn errors of immunity (IEI) include immunodeficiencies affecting cellular and humoral immunity.
OBJECTIVES: We aimed to compare the effectiveness of the lymphocyte transformation test (LTT) and carboxyfluorescein succinimidyl ester (CFSE) assays in assessing lymphocyte proliferation in IEI patients.
METHODS: We utilized radioactive (3H)-thymidine and non-radioactive CFSE to measure lymphocyte proliferation in three distinct groups: syndromic CID (SyCID), non-syndromic combined immunodeficiency (N-SyCID), and primary antibody deficiency (PAD).
RESULTS: LTT identified 8 cases of abnormal lymphocyte proliferation among all patients, whereas CFSE detected 23 cases. In the N-SyCID group, LTT identified more abnormalities than CFSE, whereas, in the SyCID and PAD groups, CFSE detected more defects. Two patients with ataxia telangiectasia and CVID had positive results on both LTT and CFSE tests, and a specific ORAI1 gene mutation resulted in differing test outcomes.
CONCLUSION: It was found that the CFSE method is a reliable and practical choice for measuring mitogenic T-cell responses in unclassified IEI patients for confirmation of immunologic diagnosis.
OBJECTIVES: We aimed to compare the effectiveness of the lymphocyte transformation test (LTT) and carboxyfluorescein succinimidyl ester (CFSE) assays in assessing lymphocyte proliferation in IEI patients.
METHODS: We utilized radioactive (3H)-thymidine and non-radioactive CFSE to measure lymphocyte proliferation in three distinct groups: syndromic CID (SyCID), non-syndromic combined immunodeficiency (N-SyCID), and primary antibody deficiency (PAD).
RESULTS: LTT identified 8 cases of abnormal lymphocyte proliferation among all patients, whereas CFSE detected 23 cases. In the N-SyCID group, LTT identified more abnormalities than CFSE, whereas, in the SyCID and PAD groups, CFSE detected more defects. Two patients with ataxia telangiectasia and CVID had positive results on both LTT and CFSE tests, and a specific ORAI1 gene mutation resulted in differing test outcomes.
CONCLUSION: It was found that the CFSE method is a reliable and practical choice for measuring mitogenic T-cell responses in unclassified IEI patients for confirmation of immunologic diagnosis.